Skip to Main Content

Hello, everyone, and how are you this fine, sunny morning? Birds are chirping and cool breezes are wafting by the Pharmalot campus today. Meanwhile, the middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? After all, you made it this far, which is a likely sign of surviving another few days. And of course, no prescription is required, which is a good thing. And while you drink up, you can peruse some of the tidbits we have assembled to help you start the day. Have a grand day, and drop us a line if you hear something saucy. …

In an ambitious move to widen access to its medical products, Pfizer plans to provide nearly two dozen patent-protected medicines and vaccines, which are already available in the U.S. or European Union, at not-for-profit prices to 45 poor countries, STAT writes. The 23 medicines and vaccines to be made available are used to treat infectious diseases, different cancers, and rare and inflammatory diseases. And as the company launches new products, these will also be included in the program on a not-for-profit basis, which means the countries would be able to purchase the drugs and vaccines at substantially lower prices than elsewhere.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment